Viewing Study NCT00838903


Ignite Creation Date: 2025-12-24 @ 7:22 PM
Ignite Modification Date: 2026-01-05 @ 5:50 PM
Study NCT ID: NCT00838903
Status: COMPLETED
Last Update Posted: 2017-01-09
First Post: 2009-02-05
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes
Sponsor: GlaxoSmithKline
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 112753
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators